Related Experiment Video
Updated: Jun 12, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Joint modeling of an outcome variable and integrated omics datasets using GLM-PO2PLS
Zhujie Gu1,2, Hae-Won Uh1, Jeanine Houwing-Duistermaat1,3,4
1Department of Data Science and Biostatistics, Julius Centre, UMC Utrecht, Utrecht, The Netherlands.
This study introduces a new one-stage method to jointly model multiple omics data and disease outcomes. This approach offers deeper insights into complex diseases by analyzing the relationships between omics and outcomes simultaneously.
Area of Science:
- Genomics and Bioinformatics
- Computational Biology
- Disease Modeling
Background:
- Human disease studies often analyze omics datasets individually, overlooking inter-omics relationships.
- Understanding the joint molecular basis of disease requires integrated analysis of multiple omics data types.
- Existing methods include dimension reduction or two-stage approaches, but holistic one-stage models are lacking.
Purpose of the Study:
- To propose a novel one-stage statistical method for jointly modeling multiple omics data and an outcome variable.
- To establish model identifiability and develop algorithms for parameter estimation.
- To derive test statistics for inferring associations between omics and outcomes.
Main Methods:
- Developed a novel one-stage statistical model integrating multiple omics and outcome variables.
- Established model identifiability and employed EM algorithms for maximum likelihood estimation.
- Proposed test statistics and derived their asymptotic distributions for association inference.
Main Results:
- The proposed method allows for joint modeling of omics data and disease outcomes.
- Identifiability and parameter estimation methods were established for normal and Bernoulli outcomes.
- Simulation studies demonstrated the model's effectiveness in evaluating associations.
Conclusions:
- The novel one-stage method provides a holistic approach to analyzing multi-omics data in disease studies.
- Jointly modeling methylation and glycomics with Down syndrome offers enhanced insights compared to individual analyses.
- This integrated approach advances the understanding of complex disease mechanisms.
More Related Videos
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Biostatistics: Overview
Discrete variables are...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Multiple Regression
Farmers can use multiple regression to determine the crop yield based on more than one factor, such as water availability, fertilizer, soil properties, etc. Here, the crop yield is the response or dependent variable as it depends on the other independent variables. The analysis requires the construction of a scatter plot...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

